Saturday, August 09, 2025 | 11:35 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jagsonpal Pharmaceuticals Ltd

Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)

04:00 PM, 13th Mar 2025

We wish to inform you that consequent to the appointment of Mr. Pratham Rawal as Company Secretary the board of directors have approved changes in KMPs authorized for purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange (s) under the Listing Regulations.

More Jagsonpal Pharmaceuticals Ltd Announcements